Table 4.

Side Effects Observed in the Patients.

Groups (N)	Dizziness, n (%)	Headache, n, (%)	Nausea, n (%)	Vomiting, n (%)	Abdominal Pain, n (%)	Diarrhea, n (%)
150 mg mf G (484)	73 (15.08%)	48 (9.92%)	195 (40.29%)	48 (9.92%)	378 (78.10%)	34 (7.02%)
125 mg mf G (483)	73 (15.11%)	45 (9.32%)	186 (38.51%)	45 (9.32%)	363 (75.16%)	33 (6.83%)
100 mg mf G (487)	69 (14.17%)	44 (9.03%)	184 (37.78%)	42 (8.62%)	a341 (70.02%)	24 (4.93%)
75 mg mf G (486)	a50 (10.29%)	32 (6.58%)	b95 (19.55%)	a29 (5.97%)	b285 (58.64%)	a15 (3.09%)
50 mg mf G (481)	b31 (6.44%)	b13 (2.70%)	b65 (13.51%)	b13 (2.70%)	b100 (20.79%)	b5 (1.04%)
P value	<.0001	<.0001	<.0001	<.0001	<.0001	<.0001

Abbreviations: mf, mifepristone; G, group.

^a P < .05, compared with the 150 mg mf group.

^b P < .001, compared with the 150 mg mf group.